Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells - Concepedia

Concepedia

Publication | Open Access

Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells

DOI Full Paper Access

53

Citations

41

References

2020

Year

Manon Lernoux, Michaël Schnekenburger, Hélène Losson, Koen Vermeulen, Hyunggu Hahn, Déborah Gérard, Jin‐Young Lee, Aloran Mazumder, Muneer Ahamed, Christo Christov,

Clinical Epigenetics

References

	Year	Citations

Page 1